Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEXT Oncology is a specialized clinical research organization and site network dedicated to Phase 1 oncology clinical trials. Founded by Dr. Anthony Tolcher, the company focuses on providing patients with access to the newest anti-cancer agents through a network of dedicated research clinics. NEXT Oncology partners with global pharmaceutical and biotechnology companies to accelerate the development of innovative cancer therapies. Their infrastructure is designed to bridge the gap between laboratory discovery and clinical application, offering advanced treatment options for patients who have exhausted standard-of-care therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEXT Oncology Specialists.